跳至主要内容
临床试验/CTRI/2019/10/021706
CTRI/2019/10/021706已完成4 期

Efficacy of Oral Psyllium versus Placebo in Pediatric Irritable Bowel Syndrome: A Double Blind Randomized Control Trial (Superiority Trail)

Jagadeesh Menon V R0 个研究点目标入组 81 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Criteria of Pediatric IBS ROME 4

排除标准

  • Children with IBS already on drug therapy or suffering from chronic diseases including, cardiac, renal and hepatic, failure to thrive, bronchial asthma, prior GI surgeries, malignancies, celiac disease, inflammatory bowel disease, cystic fibrosis, anatomical malformations of the gut, immune deficiencies, hypothyroidism, neurological and muscle diseases, and anatomical causes of bowel dysfunction will ruled out by clinical, laboratorial and radiological investigations. Child not on antibiotic therapy for atleast 4 weeks prior to enrollment

研究者

发起方
Jagadeesh Menon V R

相似试验